XERIS PHARMACEUTICALS INC's ticker is XERS and the CUSIP is 98422L107. A total of 87 filers reported holding XERIS PHARMACEUTICALS INC in Q2 2020. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2021 | $301,000 | -41.8% | 122,759 | -3.3% | 0.00% | – |
| Q2 2021 | $517,000 | -76.7% | 126,938 | -74.2% | 0.00% | – |
| Q1 2021 | $2,222,000 | -7.3% | 492,698 | +1.1% | 0.00% | – |
| Q4 2020 | $2,398,000 | -20.7% | 487,356 | -4.4% | 0.00% | -100.0% |
| Q3 2020 | $3,024,000 | +177.2% | 510,044 | +24.4% | 0.00% | – |
| Q2 2020 | $1,091,000 | +40.2% | 410,153 | +2.8% | 0.00% | – |
| Q1 2020 | $778,000 | -63.5% | 398,849 | +32.0% | 0.00% | – |
| Q4 2019 | $2,130,000 | -29.1% | 302,174 | -1.2% | 0.00% | -100.0% |
| Q3 2019 | $3,006,000 | +5.4% | 305,848 | +22.7% | 0.00% | 0.0% |
| Q2 2019 | $2,851,000 | +18.3% | 249,214 | +3.8% | 0.00% | 0.0% |
| Q1 2019 | $2,410,000 | +90.5% | 240,026 | +222.5% | 0.00% | – |
| Q4 2018 | $1,265,000 | -1.9% | 74,423 | +1.5% | 0.00% | – |
| Q3 2018 | $1,289,000 | – | 73,334 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Redmile Group, LLC | 3,000,641 | $29,496,000 | 0.99% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 2,308,666 | $22,694,000 | 0.92% |
| ArrowMark Colorado Holdings LLC | 1,656,422 | $16,283,000 | 0.16% |
| IHT Wealth Management, LLC | 57,028 | $561,000 | 0.08% |
| MOORE CAPITAL MANAGEMENT, LP | 50,000 | $492,000 | 0.02% |
| Engineers Gate Manager LP | 20,264 | $199,000 | 0.01% |
| FEDERATED HERMES, INC. | 300,000 | $2,949,000 | 0.01% |
| FMR LLC | 4,048,102 | $39,793,000 | 0.01% |
| Invesco Ltd. | 1,000,000 | $9,830,000 | 0.00% |
| MetLife Investment Management, LLC | 14,041 | $138,023 | 0.00% |